G1 Therapeutics, Inc. Insider Trading for May 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in G1 Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in G1 Therapeutics, Inc. for May 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 31 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 0.39 | 10,000 | 3,900 | 399,286 | |
| May 31 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 0.39 | 10,000 | 3,900 | 10,000 | 0 to 10 K |
| May 23 2018 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Sell | S | 50.50 | 26 | 1,313 | 4,037,711 | 4 M to 4 M (0.00 %) |
| May 23 2018 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Sell | S | 50.50 | 474 | 23,937 | 4,037,737 | 4 M to 4 M (-0.01 %) |
| May 23 2018 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Sell | S | 50.69 | 308 | 15,611 | 4,038,211 | 4 M to 4 M (-0.01 %) |
| May 23 2018 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Sell | S | 50.86 | 5,592 | 284,405 | 4,038,519 | 4 M to 4 M (-0.14 %) |
| May 23 2018 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Sell | S | 52.13 | 26 | 1,355 | 4,044,111 | 4 M to 4 M (0.00 %) |
| May 23 2018 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Sell | S | 52.13 | 474 | 24,710 | 4,044,137 | 4 M to 4 M (-0.01 %) |
| May 23 2018 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Sell | S | 51.06 | 1,595 | 81,439 | 4,044,611 | 4 M to 4 M (-0.04 %) |
| May 23 2018 | GTHX | G1 Therapeutics, I ... | Thorp Clay | 10% Owner | Sell | S | 51.16 | 29,005 | 1,483,907 | 4,046,206 | 4.1 M to 4 M (-0.71 %) |
| May 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 7,500 | 27,900 | 144,433 | |
| May 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 46.63 | 1,700 | 79,277 | 0 | 1.7 K to 0 (-100.00 %) |
| May 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 46.17 | 5,800 | 267,787 | 1,700 | 7.5 K to 1.7 K (-77.33 %) |
| May 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 7,500 | 27,900 | 7,500 | 0 to 7.5 K |
| May 16 2018 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Option Exercise | M | 4.17 | 3,776 | 15,746 | 91,951 | |
| May 16 2018 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Sell | S | 46.67 | 100 | 4,667 | 4,200 | 4.3 K to 4.2 K (-2.33 %) |
| May 16 2018 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Sell | S | 46.29 | 3,676 | 170,154 | 4,300 | 8 K to 4.3 K (-46.09 %) |
| May 16 2018 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Buy | M | 4.17 | 3,776 | 15,746 | 7,976 | 4.2 K to 8 K (+89.90 %) |
| May 07 2018 | GTHX | G1 Therapeutics, I ... | Moses Jennifer K. | VP of Finance & Adm ... | Option Exercise | M | 0.39 | 750 | 293 | 250 | |
| May 07 2018 | GTHX | G1 Therapeutics, I ... | Moses Jennifer K. | VP of Finance & Adm ... | Sell | S | 45.00 | 750 | 33,750 | 0 | 750 to 0 (-100.00 %) |
| May 07 2018 | GTHX | G1 Therapeutics, I ... | Moses Jennifer K. | VP of Finance & Adm ... | Buy | M | 0.39 | 750 | 293 | 750 | 0 to 750 |